Related Experiment Video
Updated: Dec 27, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Dilated cardiomyopathies and non-compaction cardiomyopathy
A Hänselmann1, C Veltmann1, J Bauersachs1
1Dept. of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Dilated cardiomyopathy (DCM) is a common heart failure cause, characterized by heart dilation and reduced function. Genetic diagnostics are crucial for risk stratification and understanding hereditary mechanisms in DCM patients.
Area of Science:
- Cardiology
- Genetics
- Heart Failure Research
Background:
- Dilated cardiomyopathy (DCM) is the predominant cardiomyopathy and a leading cause of heart failure.
- It involves left or biventricular dilation and impaired systolic function.
- Etiologies are diverse, including myocarditis, toxins, and systemic diseases, with peripartum cardiomyopathy as a distinct subtype.
Purpose of the Study:
- To highlight the increasing role of genetic diagnostics in identifying DCM causes.
- To emphasize the importance of genetic variants in risk stratification, particularly for arrhythmias.
- To underscore the link between genetic factors and patient prognosis in DCM.
Main Methods:
- Review of current understanding of DCM etiologies.
- Analysis of the impact of genetic diagnostics on DCM patient management.
- Integration of genetic findings with clinical risk stratification for arrhythmias and heart failure.
Main Results:
- Genetic mutations are identified in 30-50% of DCM patients.
- Advances in genetic diagnostics reveal more triggering variants and hereditary mechanisms.
- Genetic variants significantly influence the risk of arrhythmias, impacting patient prognosis.
Conclusions:
- Genetic diagnostics are pivotal in understanding and managing DCM.
- Identifying genetic variants aids in risk stratification for arrhythmias and heart failure.
- Personalized treatment strategies incorporating genetic information are essential for improving DCM patient outcomes.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy V: Interprofessional Care

